Table 13 Results of druglikeness, leadlikeness
From: Preparation and in vitro evaluation of BBG-250 loaded liposomal formulation for anticancer potential
Sl No | Compound name | Druglikeness | Leadlikeness ; violation | ||
|---|---|---|---|---|---|
Lipinski rule; Violation | Ghose rule; violation | Bioavaila- bility score | |||
1 | BBG-250 | 2 | 4 | 0.17 | 3.5 |
2 | Docetaxel | 2 | 3 | 0.17 | 2 |